A neuron with amyloid-plaques. (photo: Juan Gärtner/ Fotolia)
A neuron with amyloid-plaques. (photo: Juan Gärtner/ Fotolia)

Amyloid plaques in Alzheimer's and diabetes: Novel leads for inhibitorsPromising results with inhibitors of amyloid formation

When proteins change their structure and clump together, formation of amyloid fibrils and plaques may occur. Such “misfolding” and “protein aggregation” processes damage cells and cause diseases such as Alzheimer's and type 2 diabetes. A team of scientists from the Technical University of Munich (TUM) headed by Professor Aphrodite Kapurniotu have now developed molecules that suppress protein aggregation and could pave the way for new treatments to combat Alzheimer's, type 2 diabetes and other cell-degenerative diseases.

The scientists designed and studied 16 different peptide molecules in order to find out which of them are able to impede the “clumping” of the proteins amyloid beta (Aß) and islet amyloid polypeptide (IAPP), which are associated with Alzheimer's and type 2 diabetes.

The molecules were designed on the basis of scientific work that shows that the Aβ and IAPP proteins interact with each other, and that this “cross-amyloid interaction” suppresses their clumping. The researchers selected short sequences of the IAPP protein that correspond to the key regions involved in the interaction with the Alzheimer's protein. These "hot segments" were then chemically linked to each other by using specific peptide segments as “linkers” in order to mimic and optimize the IAPP cross-amyloid interaction surface.

Powerful inhibitors block pathologically relevant amyloid proteins in Alzheimer's and diabetes

The work performed by Professor Kapurniotu's Peptide Biochemistry team at the TUM School of Life Sciences Weihenstephan together with researchers led by Professor Bernd Reif, TUM Department of Chemistry, and Professor Gerhard Rammes at Department of Anesthesiology, TUM Klinikum Rechts der Isar, identified among the designed molecules a number of powerful inhibitors of protein clumping. Three of the new peptide molecules suppressed cytotoxic clumping of both the Alzheimer's Aβ and the type 2 diabetes IAPP. Another four designed peptides displayed selective inhibition of self-association of Aβ whereas one showed selective inhibition of IAPP clumping.

The results reveal a novel class of peptide leads that block misfolding and clumping of pathologically relevant amyloid proteins in Alzheimer's disease and type 2 diabetes, which could, in principle, be suitable for the development of therapeutics. In addition, the developed inhibitor design concept might find application in designing molecules that suppress disease-related interactions of other proteins as well.

The results of these research studies were just published in the journal 'Angewandte Chemie'. Additional studies are now underway to evaluate the potential medicinal applicability of these “test tube” results and investigate the possibility of applying the inhibitor design concept to other proteins as well. 

Publication:
Erika Andreetto, Eleni Malideli, Li-Mei Yan, Michael Kracklauer, Karine Farbiarz,Marianna Tatarek-Nossol, Gerhard Rammes, Elke Prade, Tatjana Neumüller, Andrea Caporale, Anna Spanopoulou, Maria Bakou, Bernd Reif, and Aphrodite Kapurniotu: A Hot-Segment-Based Approach for the Design of Cross-Amyloid Interaction Surface Mimics as Inhibitors of Amyloid Self-Assembly, Angewandte Chemie 2015 Sep..
DOI: 10.1002/anie.201504973

Contact:

Prof. Dr. Aphrodite Kapurniotu
Technical University of Munich
Division of Peptide Biochemistry
Tel: 0049-8161-713542
E-mail: akapurniotu@wzw.tum.de

Technical University of Munich


Article at tum.de

Legt man die zehn Strukturen mit der geringsten Energie übereinander, so zeigt die Überlagerung schön, welche Struktur das hIAPP-Molekül in einer Membranumgebung bevorzugt - eine völlig andere Struktur als das freie Molekül einnehmen würde. (Bild: Diana Rodriguez Camargo /TUM)

Snapshot of proteins that cause type 2 diabetes

When proteins misfold, accumulate and clump in insulin-producing cells in the pancreas, they can kill these cells. Now, researchers at the Technical University of Munich (TUM), the University of Michigan and the Helmholtz...

Nach Gabe eines Antagomir gegen miR92a werden Insulin (weiß) produzierende Betazellen seltener von Immunzellen (grün) angegriffen. Zudem sind mehr regulatorische T Zellen (rot) vorhanden, die die Betazellen (weiß) schützen können. (Foto: Helmholtz Zentrum München)

How does friendly fire happen in the pancreas?

In type 1 diabetes, the body attacks its own insulin-producing cells. Scientists at Technical University of Munich (TUM), at Helmholtz Zentrum München and the German Center for Diabetes Research have now reported in the...

Insulin wirkt an Stützzellen, um die Aufnahme von Zucker ins Gehirn zu regulieren. Oben ist eine solche intakte Signaltransaktion zu sehen, unten ist sie gestört. (Quelle: Garcia-Caceres)

Discovery of a brain sugar switch

Researchers at the Technical University of Munich (TUM) discovered that our brain actively takes sugar from the blood. Prior to this, researchers around the world had assumed that this was a purely passive process. An...

Farblich markierte Betazellen. Grün: mit Flattop, Rot: Mit Flattop (Foto: Helmholtz Zentrum München)

Two Kinds of Beta Cells

The marker Flattop subdivides the insulin-producing beta cells of the pancreas into those that maintain glucose metabolism and into immature cells that divide more frequently and adapt to metabolic changes. This could...

Zwei-Photonen-Mikroskopie: Aufnahme von Zellen (grün) und Amyloid-β Plaques (blau) im Alzheimer-Gehirn. (Bild: Marc Aurel Busche / TUM)

Possible Reasons Found for Failure of Alzheimer’s Treatment

Agglutinated proteins in the brain, known as amyloid-β plaques, are a key characteristic of Alzheimer’s. One treatment option uses special antibodies to break down these plaques. This approach yielded good results in the...

Räumliche Struktur des alphaB-Crystallins, eine hexamere Untereinheit ist farblich heraus gehoben – Bild: Andi Mainz / TUM

New field of application for versatile helper

In Alzheimer’s disease proteins clump together to long fibrils causing the death of nerve cells. Small heat shock proteins can counteract this effect. Scientists, therefore, hope to deploy them as agents in the treatment of...